Creative Medical Technology Holdings (CELZ) Revenue (2017 - 2025)
Creative Medical Technology Holdings' (CELZ) quarterly Revenue came in at $3000.0 in Q4 2025, little changed year-over-year from $3000.0 in Q4 2024, and little changed quarter-over-quarter from $3000.0 in Q1 2025.
Powered by 
Analysis
Creative Medical Technology Holdings (CELZ) Revenue (2017 - 2025) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Revenue for 9 consecutive years, with $3000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Revenue changed 0.0% year-over-year to $3000.0 in Q4 2025; TTM through Jun 2026 was $3000.0, a 50.0% decrease from a year earlier, with the FY2025 full-year figure at $6000.0, down 45.45% from the prior year.
- Revenue was $3000.0 for Q4 2025 at Creative Medical Technology Holdings, roughly flat from $3000.0 in the prior quarter.
- Over five years, Revenue peaked at $67754.0 in Q4 2021 and troughed at $3000.0 in Q4 2023.
- A 5-year average of $16862.8 and a median of $9000.0 in 2021 frame the typical range for Revenue.
- Across the five-year window, Revenue jumped 450.0% in 2022 and tumbled 89.09% in 2023, its largest moves.
- Over 5 years, Revenue stood at $67754.0 in 2021, then tumbled by 72.55% to $18600.0 in 2022, then slumped by 83.87% to $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025.
- The last three Revenue figures came in at $3000.0 (Q4 2025), $3000.0 (Q1 2025), and $3000.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 119.22 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 10.18 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 99.31 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 387.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 5.84 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 490,000.00 |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 54.98 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 401.25 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 77.46 Mn |
| 10 | Creative Medical Technology Holdings | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Dec 31, 2022 | 18,600.00 |
| Sep 30, 2022 | 55,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 67,754.00 |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 10,000.00 |
| Dec 31, 2020 | 17,500.00 |
| Sep 30, 2020 | 77,000.00 |
| Jun 30, 2020 | 27,900.00 |
| Mar 31, 2020 | 42,100.00 |
| Dec 31, 2019 | -4,400.00 |
| Sep 30, 2019 | 57,500.00 |
| Jun 30, 2019 | 61,600.00 |
| Mar 31, 2019 | 50,800.00 |